Evaluation of Lyme Disease
Received Date: Sep 09, 2022 / Published Date: Sep 29, 2022
Abstract
Lyme disease is a rapidly spreading infectious disease that is widespread in large parts of temperate Eurasia and North America. About 80% of patients have an erythema migrans rash, which can look like the traditional target bull'seye lesion or unrelated lesions. This rash is linked to early infection and is present in a variety of patients. Methods. The general public's capacity to recognise different erythema migrans manifestations from non-Lyme rashes was tested through a survey. By N-deacetylating chitin with a strong alkali, chitosan, a non-toxic, biocompatible, and biodegradable polymer, is created. As a bilayer skin-regenerating template, chitosan can serve as a scaffold for regeneration. Integra is a two-layer skin regeneration system made of a crosslinked fibre matrix that serves as a scaffold for renewing dermal skin cells. The "gold standard" for short-term treatment of clean burn wounds is human skin allografts (HSAs).Objectives. This study aimed to evaluate the in-vivo, preclinical biocompatibility of the Integra, HSA, and Chitosan skin-regenerating templates (SRT). Methods. To implant test materials, paravertebral subcutaneous niches were developed. After 4, 7, 14, 21, and 28 days, implants were removed.
Citation: Fauzia K (2022) Evaluation of Lyme Disease. J Bioterr Biodef, 13: 308. Doi: 10.4172/2157-2526.1000308
Copyright: © 2022 Fauzia K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 1067
- [From(publication date): 0-2022 - Aug 17, 2024]
- Breakdown by view type
- HTML page views: 899
- PDF downloads: 168